Improved survival over the last decade in pediatric patients requiring dialysis after hematopoietic cell

Jurat S Rajpal1, Niharika Patel, Rachel I Vogel

  • 1Divisions of Pediatric Nephrology and Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota, Minneapolis, MN 55455, USA.

Insights

Dialysis is a common complication after pediatric hematopoietic cell transplantation (HCT), with stable incidence over two decades. Survival for children needing dialysis post-HCT significantly improved in the 2000s compared to the 1990s.

Area of Science:

  • Pediatric Hematology
  • Nephrology
  • Transplantation Medicine

Background:

  • Fluid and electrolyte management often necessitates dialysis in pediatric patients post-hematopoietic cell transplantation (HCT).
  • Previous research indicates high mortality rates for children requiring dialysis after HCT, necessitating updated data.
  • Recent trends in dialysis incidence and outcomes following pediatric HCT are not well-documented.

Purpose of the Study:

  • To compare the incidence of dialysis in children undergoing HCT between two distinct decades (1990-1999 and 2000-2009).
  • To evaluate and compare the survival rates of pediatric HCT patients who required dialysis across these two decades.

Main Methods:

  • A retrospective review of 1427 pediatric patients (<21 years) undergoing their first HCT between 1990 and 2009 at the University of Minnesota.
  • Analysis of prospectively collected data from an institutional HCT database to determine dialysis incidence within 100 days post-HCT and 1-year survival.
  • Statistical comparisons included chi-squared tests, Fisher exact tests, Kaplan-Meier survival estimates, log-rank tests, and Cox regression analyses.

Main Results:

  • The incidence of dialysis post-HCT remained consistent between the two decades (8.2% in 1990-1999 vs. 8.9% in 2000-2009; P = .6326).
  • Patients requiring dialysis in the 2000-2009 cohort demonstrated significantly improved 1-year survival compared to the 1990-1999 cohort (23% vs. 11%; P < .0001).
  • Multivariate analysis identified older age, primary disease, pulmonary hemorrhage, and HCT during 1990-1999 as mortality predictors in dialyzed patients; cyclosporine use correlated with better survival.

Conclusions:

  • Dialysis is a persistent complication of pediatric HCT, with its incidence unchanged over the past two decades.
  • Survival outcomes for pediatric HCT patients requiring dialysis have significantly improved in the more recent decade (2000-2009).
  • Despite improvements, mortality remains higher in pediatric HCT patients requiring dialysis compared to those who do not.

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...